Jefferies Group’s Novavax NVAX Stock Holding History

Jefferies Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$408K	Hold	22,400	–	–	﹤0.01%	1113
2022 Q2	$1.15M	Hold	22,400	–	–	0.01%	758
2022 Q1	$1.65M	Buy	22,400 +10,000	+81%	+$892K	0.01%	742
2021 Q4	$1.77M	Buy	12,400 +9,900	+396%	+$1.7M	0.01%	826
2021 Q3	$518K	Buy	+2,500	New	+$551K	﹤0.01%	1217
2021 Q2	–	Sell	-9,000	Closed	-$1.63M	–	1900
2021 Q1	$1.63M	Sell	9,000 -63,000	-88%	-$12.6M	0.01%	746
2020 Q4	$8.03M	Sell	72,000 -5,000	-6%	-$531K	0.06%	277
2020 Q3	$8.34M	Sell	77,000 -253,000	-77%	-$30.8M	0.09%	179
2020 Q2	$27.5K	Buy	330,000 +180,000	+120%	+$6.88M	0.32%	35
2020 Q1	$2.04M	Buy	+150,000	New	+$1.27M	0.02%	682
2019 Q2	–	Sell	-1,220	Closed	-$13K	–	2773
2019 Q1	$13K	Hold	1,220	–	–	﹤0.01%	2257
2018 Q4	$45K	Buy	+1,220	New	+$47.3K	﹤0.01%	2032
2016 Q4	–	Sell	-3,230	Closed	-$134K	–	2389
2016 Q3	$134K	Buy	3,230 +1,980	+158%	+$256K	﹤0.01%	2004
2016 Q2	$182K	Buy	+1,250	New	+$143K	﹤0.01%	1841
2015 Q4	–	Sell	-22,505	Closed	-$3.18M	–	2478
2015 Q3	$3.18M	Buy	22,505 +14,680	+188%	+$3.29M	0.02%	688
2015 Q2	$1.74M	Hold	7,825	–	–	0.01%	981
2015 Q1	$1.29M	Buy	+7,825	New	+$1.27M	0.01%	932

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's NVAX Position: Q3 2022 in Review

Jefferies Group opened a new position in Novavax (NVAX) in Q3 2022: 70 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Jefferies Group previously reported a position in NVAX as recently as Q1 2022.

Jefferies Group first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $3.9M in Q4 2020. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

Jefferies Group held 70 shares of Novavax worth $1.27K as of Q3 2022.
Novavax was a new Jefferies Group position in Q3 2022.
Novavax made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1594 holding.
Jefferies Group first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
Jefferies Group's Novavax position peaked at $3.9M in Q4 2020.
253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.